These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34591980)

  • 1. Neuroinflammation and immunoregulation in glioblastoma and brain metastases: Recent developments in imaging approaches.
    Roesler R; Dini SA; Isolan GR
    Clin Exp Immunol; 2021 Dec; 206(3):314-324. PubMed ID: 34591980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of radiomics and machine learning for radiotherapy of malignant brain tumors.
    Kocher M; Ruge MI; Galldiks N; Lohmann P
    Strahlenther Onkol; 2020 Oct; 196(10):856-867. PubMed ID: 32394100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Dynamic O-(2-[
    Lohmann P; Piroth MD; Sellhaus B; Weis J; Geisler S; Oros-Peusquens AM; Mohlberg H; Amunts K; Shah NJ; Galldiks N; Langen KJ
    World Neurosurg; 2018 Nov; 119():e653-e660. PubMed ID: 30077752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the application of neuroinflammatory molecular imaging in brain malignancies.
    Dong W; Wang N; Qi Z
    Front Immunol; 2023; 14():1211900. PubMed ID: 37533851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-human assessment of the novel LAT1 targeting PET probe
    Nozaki S; Nakatani Y; Mawatari A; Hume WE; Wada Y; Ishii A; Tanaka M; Tsuyuguchi N; Doi H; Watanabe Y
    Biochem Biophys Res Commun; 2022 Mar; 596():83-87. PubMed ID: 35121373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
    Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
    Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
    Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Nozaki S; Nakatani Y; Mawatari A; Shibata N; Hume WE; Hayashinaka E; Wada Y; Doi H; Watanabe Y
    Sci Rep; 2019 Oct; 9(1):15718. PubMed ID: 31673030
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kong Z; Jiang C; Zhu R; Feng S; Wang Y; Li J; Chen W; Liu P; Zhao D; Ma W; Wang Y; Cheng X
    Neuroimage Clin; 2019; 23():101912. PubMed ID: 31491820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
    Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Kitamura Y; Mizoguchi M; Yoshimoto K; Kuga D; Suzuki SO; Baba S; Isoda T; Iwaki T; Iihara K; Honda H
    J Magn Reson Imaging; 2016 Nov; 44(5):1256-1261. PubMed ID: 27093558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of glioblastomas from metastatic brain tumors by tryptophan uptake and kinetic analysis: a positron emission tomographic study with magnetic resonance imaging comparison.
    Kamson DO; Mittal S; Buth A; Muzik O; Kupsky WJ; Robinette NL; Barger GR; Juhász C
    Mol Imaging; 2013; 12(5):327-37. PubMed ID: 23759373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between glioblastoma, brain metastasis and subtypes using radiomics analysis.
    Artzi M; Bressler I; Ben Bashat D
    J Magn Reson Imaging; 2019 Aug; 50(2):519-528. PubMed ID: 30635952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging.
    Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Reardon DA; Coleman RE
    Mol Imaging Biol; 2006; 8(6):340-7. PubMed ID: 17051323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
    Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating solitary brain metastases from glioblastoma by radiomics features derived from MRI and 18F-FDG-PET and the combined application of multiple models.
    Cao X; Tan D; Liu Z; Liao M; Kan Y; Yao R; Zhang L; Nie L; Liao R; Chen S; Xie M
    Sci Rep; 2022 Apr; 12(1):5722. PubMed ID: 35388124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors.
    Overcast WB; Davis KM; Ho CY; Hutchins GD; Green MA; Graner BD; Veronesi MC
    Curr Oncol Rep; 2021 Feb; 23(3):34. PubMed ID: 33599882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors.
    Jaber M; Wölfer J; Ewelt C; Holling M; Hasselblatt M; Niederstadt T; Zoubi T; Weckesser M; Stummer W
    Neurosurgery; 2016 Mar; 78(3):401-11; discussion 411. PubMed ID: 26366972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of advanced MRI techniques for the peritumoural region in differentiating glioblastoma multiforme and solitary metastatic lesions.
    Lee EJ; Ahn KJ; Lee EK; Lee YS; Kim DB
    Clin Radiol; 2013 Dec; 68(12):e689-97. PubMed ID: 23969153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.
    Bosnyák E; Kamson DO; Robinette NL; Barger GR; Mittal S; Juhász C
    J Neurooncol; 2016 Jan; 126(2):317-25. PubMed ID: 26514361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome.
    Bartos LM; Quach S; Zenatti V; Kirchleitner SV; Blobner J; Wind-Mark K; Kolabas ZI; Ulukaya S; Holzgreve A; Ruf VC; Kunze LH; Kunte ST; Hoermann L; Härtel M; Park HE; Groß M; Franzmeier N; Zatcepin A; Zounek A; Kaiser L; Riemenschneider MJ; Perneczky R; Rauchmann BS; Stöcklein S; Ziegler S; Herms J; Ertürk A; Tonn JC; Thon N; von Baumgarten L; Prestel M; Tahirovic S; Albert NL; Brendel M
    Clin Cancer Res; 2024 Oct; 30(20):4618-4634. PubMed ID: 39150564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.